# Proposed Data Collection Submitted for Public Comment and Recommendations

> Briefs, arguments, decisions, and more.

URL: https://www.frixlaw.com/law-library/documents/fr%3A2017-27482

## Record

- **Collection:** Federal Register
- **Document type:** Notice
- **Published:** December 21, 2017
- **Citation:** 82 FR 60608

## Text

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-18-0978; Docket No. CDC-2017-0116]
Proposed Data Collection Submitted for Public Comment and Recommendations

AGENCY:

Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

ACTION:

Notice with comment period.

SUMMARY:

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled
Emerging Infections Program,
a population-based surveillance via active, laboratory case finding that is used for detecting, identifying, and monitoring emerging pathogens.

DATES:

CDC must receive written comments on or before February 20, 2018.

ADDRESSES:

You may submit comments, identified by Docket No. CDC-2017-0116 by any of the following methods:

•
Federal eRulemaking Portal: Regulations.gov
. Follow the instructions for submitting comments.

•
Mail:
Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS-D74, Atlanta, Georgia 30329.

Instructions:
All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to
Regulations.gov
.

Please note:
Submit all Federal comments through the Federal eRulemaking portal (
regulations.gov
) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT:

To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
omb@cdc.gov.

SUPPLEMENTARY INFORMATION:

Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the
Federal Register
concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below.

The OMB is particularly interested in comments that will help:

1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;

2. Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;

3. Enhance the quality, utility, and clarity of the information to be collected; and

4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology,
e.g.,
permitting electronic submissions of responses.

5. Assess information collection costs.

Proposed Project

Emerging Infections Program (OMB Control Number 0920-0978, Expiration Date 2/28/2019)—Revision—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

The Emerging Infections Programs (EIPs) are population-based centers of excellence established through a network of state health departments collaborating with academic institutions; local health departments; public health and clinical laboratories; infection control professionals; and healthcare providers. EIPs assist in local, state, and national efforts to prevent, control, and monitor the public health impact of infectious diseases.

Activities of the EIPs fall into the following general categories: (1) Active surveillance; (2) applied public health epidemiologic and laboratory activities; (3) implementation and evaluation of pilot prevention/intervention projects; and (4) flexible response to public health emergencies. Activities of the EIPs are designed to: (1) Address issues that the EIP network is particularly suited to investigate; (2) maintain sufficient flexibility for emergency response and new problems as they arise; (3) develop and evaluate public health interventions to inform public health policy and treatment guidelines; (4) incorporate training as a key function; and (5) prioritize projects that lead directly to the prevention of disease.

A revision is being submitted to make existing forms clearer and to add several new forms: ABCs Severe GAS Infection Supplemental Form, HAIC Multi-site Gram-Negative Bacilli Case Report Form for Carbapenem-resistant Pseudomonas aeruginosa (CR-PA), HAIC Multi-site Gram-Negative Surveillance Initiative—Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (MuGSI-ESBL), HAIC Invasive Methicillin-sensitive Staphylococcus aureus (MSSA), and HAIC Candidemia Case Report Form. These forms will allow the EIP to better detect, identify, and monitor emerging pathogens. The estimates of the infection incidence generated by this collection provide the foundation for a variety of epidemiologic studies to explore risk factors, spectrum of disease, and prevention strategies.

The total estimated burden is 40,347 hours. There is no cost to respondents other than their time.

Estimated Annualized Burden Hours

Type of respondents
Form name

Number of
respondents

Number of
responses per
respondent

Average
burden per
response
(in hours)

Total
burden
(in hours)

State Health Department
ABCs Case Report Form
10
809
20/60
2,697

ABCs Invasive Pneumococcal Disease in Children Case Report Form
10
22
10/60
37

ABCs Surveillance for Non-Invasive Pneumococcal Pneumonia (SNiPP) Case Report Form
10
125
10/60
208

ABCs
H.influenzae
Neonatal Sepsis Expanded Surveillance Form

10
6
10/60
10

ABCs Severe GAS Infection Supplemental Form—NEW FORM
10
136
20/60
453

ABCs Neonatal Infection Expanded Tracking Form
10
37
20/60
123

FoodNet Campylobacter
10
850
21/60
2,975

FoodNet Cryptosporidium
10
130
10/60
217

FoodNet Cyclospora
10
3
10/60
5

FoodNet Listeria monocytogenes
10
13
20/60
43

FoodNet Salmonella
10
827
21/60
2,895

FoodNet Shiga toxin producing E. coli
10
190
20/60
633

FoodNet Shigella
10
290
10/60
483

FoodNet Vibrio
10
25
10/60
42

FoodNet Yersinia
10
30
10/60
50

FoodNet Hemolytic Uremic Syndrome
10
10
1
100

Influenza Hospitalization Surveillance Network Case Report Form
10
1,000
25/60
4,167

Influenza Hospitalization Surveillance Project Vaccination Phone Script Consent Form (English)
10
333
5/60
278

Influenza Hospitalization Surveillance Project Vaccination Phone Script Consent Form (Spanish)
10
333
5/60
278

Influenza Hospitalization Surveillance Project Provider Vaccination History Fax Form (Children/Adults)
10
333
5/60
278

HAIC CDI Case Report Form
10
1,650
30/60
8,250

HAIC Multi-site Gram-Negative Bacilli Case Report Form
(MuGSI-CRE/CRAB)

10
500
20/60
1,667

HAIC Multi-site Gram-Negative Bacilli Case Report Form for Carbapenem-resistant
Pseudomonas aeruginosa
(CR-PA)—NEW FORM

10
344
45/60
2,580

HAIC Multi-site Gram-Negative Surveillance Initiative—Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (MuGSI-ESBL)—NEW FORM
10
1,200
20/60
4,000

HAIC Invasive Methicillin-resistant
Staphylococcus aureus
(MRSA)

10
609
20/60
2,030

HAIC Invasive Methicillin-sensitive
Staphylococcus aureus
(MSSA)—NEW FORM

10
1,035
20/60
3,450

HAIC Candidemia Case Report Form—NEW FORM
9
800
20/60
2,400

Total

40,347

Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention.

[FR Doc. 2017-27482 Filed 12-20-17; 8:45 am]
BILLING CODE 4163-18-P

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/documents/fr%3A2017-27482. Public record. Not legal advice.